🚀 NKE: $1.9M 3-Year LEAPS Bet on Nike's Epic Turnaround!
📅 December 24, 2024 | 🔥 EXTREMELY UNUSUAL Activity Detected (Z-Score: 3.72)
🎯 The Quick Take
Someone just bet $1.9 MILLION on Nike with a 3-YEAR LEAPS call expiring in January 2028! This isn't your typical options play - this is a massive long-term conviction bet that Nike will climb from $60 to $70+ over the next three years. With new CEO Elliott Hill executing a turnaround and insiders buying millions worth of stock, big money is positioning for Nike's comeback story. 👀
💰 The Option Flow Breakdown
📊 What Just Happened
Trade Details:
| Field | Value |
|---|---|
| Ticker | NKE |
| Date | December 24, 2024 |
| Time | 10:35:50 ET |
| Option Symbol | NKE20280121C70 |
| Strategy | Long Call (LEAPS) |
| Premium Paid | $1,900,000 |
| Contracts | 1,999 |
| Strike Price | $70.00 |
| Expiration | January 21, 2028 (3 YEARS!) |
| Spot Price | $60.09 |
| Option Price | $9.30 |
| Volume | 2,400 |
| Open Interest | 5,800 |
| Unusualness | EXTREMELY UNUSUAL (Z-Score 3.72) |
🤓 What This Actually Means
Real talk: This is NOT a typical weekly or monthly options play. This is a three-year conviction bet that speaks volumes:
🎯 The Buyer's Thesis:
- Strike at $70 is 16.5% above current price ($60.09) - they're betting on serious appreciation
- Willing to pay $1.9M in premium for 3 years of exposure
- Z-Score of 3.72 means this trade is 372% more unusual than normal activity - happens only a few times per year
- Not day trading - this is strategic positioning for 2025-2028 turnaround
🐋 Why This Matters:
- LEAPS buyers typically = institutional money or ultra-high-net-worth individuals
- Three-year time horizon suggests insider-level conviction about Hill's turnaround plan
- Timing aligns with major product launches (Project Amplify 2025, Nike Mind Jan 2026)
- Recent insider buying validates thesis: Tim Cook bought $2.95M, Robert Swan $500K in December 2024
🏢 Company Overview
Nike Inc (NYSE: NKE) - The world's largest athletic footwear and apparel company
💼 Key Stats:
- Market Cap: ~$115 billion
- Current Price: $60.09
- Industry: Athletic footwear, apparel, equipment
- YTD Performance: -24.2% (down from highs, creating opportunity)
What They Do: Nike designs, develops, markets and sells athletic footwear, apparel, equipment and accessories. The Swoosh is one of the most recognized brands globally with presence in 170+ jurisdictions. Think Jordan Brand, Air Max, innovative performance running shoes, and lifestyle sneakers.
Current Situation: Nike is executing a comprehensive turnaround under new CEO Elliott Hill who returned in October 2024 after 32 years with the company. He's reversing previous DTC-heavy strategy to rebuild wholesale partnerships, cutting promotions, and accelerating innovation pipeline.
📈 Technical Setup / Chart Check-Up
YTD Chart Review

The Story in the Chart: Nike is down -24.2% YTD - that's a brutal year. But here's what's interesting:
📉 The Pain Points:
- Stock fell from ~$115 highs to current $60 level
- Q2 earnings (Dec 19) showed revenue down 8% to $12.4B, China down 17%
- Margin compression from $1.5B tariff headwinds
📈 The Silver Linings:
- Price stabilizing in $60-70 range after sharp decline
- New leadership fully in place as of December 2024
- Insider buying surge ($3.5M+ in December) signals bottom formation
- Classic "blood in the streets" setup for contrarian long-term plays
💡 For LEAPS Buyers: This YTD decline creates attractive entry for 3-year bet. If turnaround succeeds, upside is massive.
Gamma-Based Support & Resistance Analysis

What Gamma Levels Tell Us:
Options activity creates natural support and resistance zones where market makers hedge their positions. Bigger bars = stronger levels where price tends to stick or bounce.
🔵 Put Gamma Support Levels (Below Current $60.09):
- $60.00 - STRONGEST SUPPORT (111.5M total GEX, net bearish -21.3M)
- Just 0.04% below current price - this is the critical floor
- Heavy put walls here suggest institutions defending $60
- $57.50 - Secondary Support (13.3M total GEX)
- 4.2% below spot, would be significant breakdown level
- $55.00 - Deep Support (16.3M total GEX)
- 8.4% below spot, catastrophic scenario level
🟠 Call Gamma Resistance Levels (Above Current $60.09):
- $61.00 - Immediate Resistance (11.0M total GEX)
- Just 1.6% above spot - near-term ceiling to break
- $65.00 - Major Resistance (27.7M total GEX, nearly balanced)
- 8.3% above spot - first meaningful target for bulls
- Note: LEAPS strike at $70 is well above this level
- $70.00 - ULTIMATE RESISTANCE (14.2M total GEX)
- 16.6% above spot - EXACTLY where LEAPS strike is
- This is the battleground price for 2025-2028
Net GEX Bias: Bearish (-15.5M net negative) suggests market makers currently positioned for downside, but LEAPS buyer is betting this flips.
Implied Move Analysis

What Options Market Expects:
The implied volatility baked into options prices tells us what the market thinks is possible:
📅 Short-Term (Weekly - Dec 26, 2024):
- Implied Move: ±0.96% ($0.58)
- Range: $59.55 - $60.71
- Translation: Quiet holiday week expected
📅 Medium-Term (Monthly OPEX - Jan 16, 2026):
- Implied Move: ±4.44% ($2.67)
- Range: $57.46 - $62.80
- Translation: Market pricing moderate volatility into year-end
📅 Quarterly (Triple Witch - March 20, 2026):
- Implied Move: ±10.25% ($6.16)
- Range: $53.97 - $66.29
- Key Catalyst: Q3 Earnings on March 20, 2025 falls right on this expiration
- Translation: Big earnings volatility expected
📅 Long-Term (Yearly LEAPS - Dec 18, 2026):
- Implied Move: ±22.55% ($13.56)
- Range: $46.57 - $73.69
- Upper range at $73.69 exceeds LEAPS strike of $70
- Translation: Market gives LEAPS buyer ~50% probability of success by late 2026
💡 For The Trade: The 3-year LEAPS expires Jan 2028, giving even more time than the yearly implied move window. Buyer has cushion for turnaround execution.
🎪 Catalysts
🚀 Upcoming Catalysts (What's Next)
Q3 FY2025 Earnings - March 20, 2025 🔥
- Timing: March 20, 2025, ~1:15 PM PT after market close
- Expected: Low single-digit revenue decline, gross margin down 175-225 bps
- Why It Matters: First earnings showing wholesale recovery momentum and China stabilization progress
- Implied Move: Market pricing ±10.25% move around this date
- Bull Case: If China shows signs of bottoming and wholesale partnerships gain traction, could spark major rally
- Bear Risk: Further margin compression or worse China deterioration tanks stock
- Source: Nike Investor Relations
Product Launch: Air Max Dn8 - February/March 2025 🔥
- Launch Dates: Feb 6 (SNKRS), March 6 (global nike.com)
- What It Is: Dynamic Air technology flagship for Air Max Day 2025
- Why It Matters: Tests consumer appetite for premium innovation (14 colorways through spring)
- Bull Case: Strong sell-through validates innovation strategy, drives margin expansion
- Source: Nike.com
Q4 FY2025 Earnings - June 26, 2025 🔥
- Timing: June 26, 2025
- Why It Matters: First full-year results under Elliott Hill's leadership
- Management Guidance: "Q4 will show largest impact from repositioning actions"
- Bull Case: Turnaround showing tangible results could re-rate stock
- Bear Risk: If improvement not visible by Q4, patience wears thin
- Source: Zacks
Product Launch: Project Amplify - 2025 🚀
- What It Is: World's first powered footwear system - lightweight motor + rechargeable battery for running/walking
- Target Market: Everyday athletes (10-12 min/mile pace)
- Why It Matters: Could create entirely new category like e-bikes did for cycling
- Revolutionary Potential: If successful, this is iPhone-level product innovation
- Bull Case: New category adds billions in TAM, validates Nike as innovation leader
- Source: Nike Newsroom
Product Launch: Nike Mind Platform - January 2026 🚀
- Launch Date: January 2026 at nike.com and select retail
- What It Is: First neuroscience-based footwear activating sensory receptors for mind-body connection
- Development: More than decade in the making
- Why It Matters: Premium positioning in lifestyle/wellness mega-trend
- Bull Case: Taps into $431.7B athleisure market growing to $1.06T by 2034
- Source: Nike Newsroom
Dividend Payment - January 2, 2025 💰
- Amount: $0.40/share
- Annual Yield: 2.76%
- 5-Year Growth: +9.77%
- Why It Matters: Confirms financial stability during turnaround
- Source: Nike Investor Relations
📉 Recent Catalysts (What Already Happened)
Q2 FY2025 Earnings - December 19, 2024 (Mixed)
- Results: Revenue $12.4B (-8% YoY), EPS $0.78 (beat estimates)
- The Bad: China down 17% (6th consecutive quarterly decline), gross margin down 100 bps
- The Good: Beat earnings expectations despite tough conditions
- Market Reaction: Stock initially dipped then stabilized
- Takeaway: Confirmed turnaround will take time, but execution starting
- Source: Nike Investor Relations
CEO Leadership Transition - October 14, 2024 (Bullish)
- Change: Elliott Hill replaced John Donahoe as CEO
- Background: Hill is 32-year Nike veteran who came out of retirement
- Strategic Shift: Return to sport focus, rebuild wholesale, cut promotions
- Why It Matters: Experienced operator who knows Nike DNA vs. tech executive
- Validation: Leadership team fully set as of Dec 2024 with 10+ title changes
- Source: Business Chief
Insider Buying Wave - December 2024 (VERY Bullish)
- Tim Cook: Bought $2.95M worth of NKE stock
- Robert Swan: Bought $500K worth
- Total: $3.45M+ in insider purchases
- Why It Matters: Directors putting personal money where their mouth is = confidence
- Market Reaction: Stock rose 2% in pre-market on news
- Takeaway: Insiders buying at $60-76 range suggests floor formation
- Source: GuruFocus
Analyst Downgrades Post-Q2 - December 19-21, 2024 (Bearish)
- UBS: Lowered PT to $62 from $71
- Goldman Sachs: Lowered PT to $77 from $89
- Truist: Lowered PT to $70 from $85
- New Consensus: $80.50 average (range $62-$120)
- Why It Matters: Wall Street resetting expectations lower creates upside surprise potential
- Contrarian View: When analysts capitulate, often marks bottom
- Source: TipRanks
Wholesale Partnership Renewals - 2024 (Bullish)
- Foot Locker: Teams met in Portland to plan "return to growth"
- Dick's Sporting Goods: Joint loyalty program launched, expanded product selection
- Dick's-Foot Locker Merger (2025): Analysts view as positive, combined entity 38% Nike sales
- Why It Matters: Reverses previous DTC-heavy mistake, reclaims shelf space from competitors
- Takeaway: Distribution strategy back on track
- Source: Modern Retail
🎲 Price Targets & Probabilities
Based on gamma levels, implied moves, and fundamental catalysts, here's how the next 6-12 months could play out:
🚀 Bull Case (35% Probability): $70-75 by Q4 2025
Path to Victory:
- China stabilizes by Q3 2025, showing sequential improvement
- Wholesale partnerships drive revenue reacceleration in North America
- Project Amplify or Nike Mind launches exceed expectations
- Tariff mitigation cuts margin headwind from 320 bps to 120 bps as planned
- Market re-rates stock on visible turnaround progress
Key Resistance Levels to Break:
- $61 - Immediate ceiling (1.6% above spot)
- $65 - Major gamma resistance (8.3% above spot)
- $70 - LEAPS strike / ultimate target (16.6% above spot)
Probability Assessment: 35% chance of reaching $70+ by late 2025
- Requires multiple catalysts breaking right
- Historical turnarounds take 12-18 months to show results
- Insider buying + LEAPS positioning suggests informed money believes it's possible
⚖️ Base Case (45% Probability): $55-65 Trading Range
Most Likely Scenario:
- Stock consolidates in current range while turnaround plays out
- Q3/Q4 earnings show modest improvement but not explosive growth
- China remains weak but stops deteriorating
- Wholesale partnerships progress slowly
- Innovation pipeline builds anticipation for 2026
Trading Range:
- Support: $57.50-60.00 (gamma support cluster)
- Resistance: $62.50-65.00 (gamma resistance cluster)
- Implied Move Range: $57.46-$66.29 by March 2026 quarterly expiration
Probability Assessment: 45% chance of sideways action through mid-2025
- Turnaround takes time, Hill himself said "it's not linear"
- Market needs proof points before re-rating
- LEAPS buyer has 3 years for thesis to play out
😰 Bear Case (20% Probability): $50-55 Breakdown
What Could Go Wrong:
- China deterioration accelerates (another -15-20% decline in Q3/Q4)
- Tariffs escalate beyond $1.5B current impact
- On Running, Hoka continue stealing market share in performance
- Adidas gains more ground in lifestyle with retro styles
- Product launches (Amplify, Mind) flop or get delayed
- Recession kills premium athletic spend
Critical Support Levels:
- $57.50 - First major support breach (4.2% below spot)
- $55.00 - Deep support (8.4% below spot)
- $53.97 - Quarterly implied move lower bound
Probability Assessment: 20% chance of breakdown below $55
- Requires multiple negative catalysts
- Current support levels relatively strong
- Insider buying suggests floor near current levels
- Even in bear case, LEAPS buyer has 3 years to recover
💡 Trading Ideas
🛡️ Conservative: "I Want The Dividend While I Wait"
Strategy: Buy shares + sell covered calls
The Play:
- Buy 100 shares of NKE at $60.09 = $6,009
- Sell 1x March 2025 $65 call for ~$1.50 = collect $150
- Collect $0.40/share dividend on Jan 2 = $40
Why This Works:
- You get 2.76% dividend yield while waiting for turnaround
- Covered call generates additional 2.5% income over 3 months
- If stock rallies to $65, you profit ~$5/share (8.3%) + keep premium + dividend
- If stock stays flat/down, premium + dividend cushions downside
- Total potential return: ~10% in 3 months if called away, 5% if not
Risk Level: Low
- You own the stock (not as risky as naked options)
- Protected by dividend and covered call income
- Worst case: Stock drops below $60, but you collect income while holding
Who This Is For: Value investors who want Nike exposure but need income generation while turnaround plays out
⚖️ Balanced: "The LEAPS Lite Version"
Strategy: Buy longer-dated calls (12-18 month)
The Play:
- Buy 1x January 2026 $65 call (12 months out) for ~$4.50 = $450
- Strike 8.3% above current price
- Breakeven: $69.50 at expiration
Why This Works:
- Similar thesis to the $1.9M trade but shorter timeframe and lower strike
- One year gives turnaround time to show progress
- Covers Q3 2025 earnings (March), Q4 2025 earnings (June), and into FY2026
- Major product launches (Air Max Dn8, Project Amplify) should show results by then
- Lower strike ($65 vs $70) means you don't need as much appreciation
Risk Level: Medium
- Options can expire worthless if turnaround takes longer than expected
- You risk $450 per contract
- Max loss: 100% of premium if stock below $65 at expiration
- Max gain: Unlimited above $69.50
Who This Is For: Swing traders who believe in turnaround but want less capital commitment than 3-year LEAPS
🚀 Aggressive: "Shadow The Smart Money"
Strategy: Buy 3-year LEAPS calls like the whale
The Play:
- Buy 1x January 2028 $70 call (same as the $1.9M trade) for ~$9.30 = $930
- Strike 16.6% above current price
- Breakeven: $79.30 at expiration (31.9% above current)
Why This Works:
- You're literally copying the trade that triggered this alert
- Three-year timeframe gives turnaround PLENTY of time to work
- Covers all major catalysts: Q3-Q4 FY2025 earnings, Project Amplify launch (2025), Nike Mind launch (Jan 2026), plus all of 2027
- If Nike hits $80+ by 2028 (analyst consensus), this could be 5-10x return
- Insider buying + institutional LEAPS buying = informed money positioning for recovery
- Time decay is SLOW on 3-year LEAPS (theta very low)
Risk Level: High
- $930 per contract at risk
- Needs stock to reach $79.30 just to break even (31.9% appreciation)
- If turnaround fails, you lose 100% of premium
- That said, you have 3 YEARS for thesis to play out vs. typical options
Advanced Move - Diagonal Spread:
- Buy 1x Jan 2028 $70 call for $9.30 = -$930
- Sell 1x March 2025 $65 call for $1.50 = +$150
- Net cost: $780
- You collect premium on short-term calls while holding long-term position
- Can repeat short call sales quarterly to reduce cost basis
Who This Is For:
- Risk-tolerant traders with conviction in Nike turnaround
- People who can afford to lose the premium and want leverage on recovery
- Those who believe Hill's track record + innovation pipeline = success
- NOT for those who need the money in <3 years
⚠️ Risk Factors
Real talk - let's be honest about what could go wrong:
Turnaround Timeline Risk (HIGH) 😰
- CEO Hill explicitly said: "It's gonna take a while. It's not linear."
- Analysts warn: "Nike has a long road to travel... this will not happen overnight"
- Reality Check: Recovery could extend into FY2027 vs. market hoping for FY2026
- Impact on Trade: LEAPS buyers have cushion, but shorter-dated calls could expire worthless
China Catastrophe (MEDIUM-HIGH) 😰
- Six consecutive quarters of decline, Q2 down 17%, footwear down 21%, online down 36%
- Strategy reset required - moving from lifestyle back to sport positioning
- What If: Another 10-15% decline in Q3-Q4 possible before stabilization
- Impact: Could add $500M-$750M revenue headwind, delay margin recovery
Tariff Escalation (MEDIUM) 😰
- Current hit: $1.5B annual costs (320 bps margin headwind)
- Vietnam tariffs approaching 46% on key production (60% apparel, 95% footwear from Vietnam/China/Cambodia)
- What If: Additional tariff increases could add $500M-$1B costs if geopolitical tensions escalate
- Mitigation: Nike shifting production to Indonesia, Philippines, Mexico (targeting 120 bps net impact)
Competitor Momentum (MEDIUM) 🏃
- On Running & Hoka gaining market share in performance running
- Adidas winning lifestyle with Sambas, Gazelles, Campus retro styles
- Market Share Erosion: Nike dropped from 15.2% (2023) to 14.1% (2024) globally
- Risk: Could lose another 50-100 bps share in 2025 if innovation pipeline delays
Macro Headwinds (LOW-MEDIUM) 🌍
- Consumer spending pressure in potential recession
-
40% revenue from North America = high US economic sensitivity
- Premium product focus may face resistance if economy weakens
- Impact: Could delay recovery by 6-12 months
Product Launch Execution (MEDIUM) 🎮
- Project Amplify: Revolutionary but unproven - could flop like Google Glass
- Nike Mind: Decade in development but niche neuroscience positioning = uncertain TAM
- What If: Launches disappoint, get delayed, or face production issues
- Impact: Would undermine innovation narrative, keep stock in penalty box
Margin Compression (HIGH) 😰
- Q2 gross margin down 300 bps to 40.6%
- Q3 guidance: Down 175-225 bps (including 315 bps tariff impact)
- China inventory obsolescence reserves increased
- Risk: If promotional environment worsens or tariffs escalate, margin recovery delays
- Impact: EPS expectations already down 48% YoY for FY2025 - could get worse
🎯 The Bottom Line
Here's the deal: This $1.9M 3-year LEAPS trade is one of the most compelling institutional bets I've seen in months. It's not a lottery ticket - it's a calculated conviction play on Nike's turnaround.
Why The Smart Money Is Betting Big:
✅ New Leadership: Elliott Hill is the real deal - 32-year Nike veteran who knows the company DNA, not a tech outsider
✅ Insider Validation: $3.45M in director buying in December 2024 (Tim Cook $2.95M, Robert Swan $500K) confirms bottom formation
✅ Innovation Pipeline: Project Amplify (powered footwear) + Nike Mind (neuroscience footwear) could be category-defining products
✅ Wholesale Fixed: Partnerships with Foot Locker and Dick's back on track after previous DTC mistake
✅ Valuation: Down 24% YTD creates asymmetric risk/reward for long-term holders
✅ Time Horizon: 3 YEARS is plenty of runway for turnaround to work (vs. quarterly traders)
What Could Derail This:
❌ China Keeps Bleeding: Already down 6 consecutive quarters (-17% in Q2) - needs to stabilize
❌ Margin Pressure: $1.5B tariff costs + promotional environment could delay profitability recovery
❌ Execution Risk: Turnaround explicitly "not linear" per CEO - could take until 2027
❌ Competition: On, Hoka, Adidas gaining share while Nike resets
My Take:
If you own NKE stock already → Hold through turnaround. Consider selling covered calls against it to generate income while you wait.
If you're watching from sidelines → Mark March 20, 2025 earnings on your calendar. If China shows stabilization and wholesale momentum builds, consider entry.
If you're aggressive trader → The January 2026 $65 calls (~$450) offer similar thesis with less capital at risk than 3-year LEAPS.
If you're ultra-conviction → Shadow the whale with Jan 2028 $70 calls (~$930), but only with money you can afford to lose. This is a 3-year chess match, not a weekly lottery ticket.
Biggest Lesson: When insiders buy millions + institutions bet $1.9M on 3-year LEAPS + new CEO with 32-year track record executes turnaround → PAY ATTENTION. This isn't noise. This is signal.
The LEAPS buyer isn't betting on a quick flip. They're betting Elliott Hill + innovation pipeline + wholesale recovery = Nike back to $70-80+ by 2027-2028. Three years is a long time in markets, but turnarounds take time.
Your move. 🎯
⚖️ Disclaimer
This analysis is for educational and informational purposes only and should not be considered financial advice. Options trading involves substantial risk and is not suitable for all investors. You can lose 100% of your investment in options. The $1.9M LEAPS trade described represents sophisticated institutional activity - individual investors should carefully consider their risk tolerance, time horizon, and financial situation before making any trades. Past performance does not guarantee future results. Always consult with a qualified financial advisor before making investment decisions.
The author may or may not hold positions in the securities discussed.
Analysis based on trade data from December 24, 2024. Nike catalyst research and market data current as of publication date. Options Greeks, implied moves, and gamma levels are dynamic and change throughout the trading day.
Key Sources: